Crocus sativus L. · herb
Evidence tier: moderate
One of the most evidence backed natural mood supports. Particularly helpful for low mood with appetite changes.
Proposed, not proven. Crocin and safranal are thought to inhibit serotonin reuptake and to support BDNF expression, which is the standard monoamine story and would explain non inferiority to an SSRI if it were true in people. It rests on animal and cell work. No human study has demonstrated that this is the operating mechanism.
Moderate, and the surprise in this batch is that the evidence is genuinely there. Saffron is one of the few botanicals to have been tested head to head against prescription antidepressants and to have held its ground. A meta analysis in Nutrition Reviews (2024, PMID 38913392) pooled 8 RCTs comparing saffron with SSRIs for depression and found no significant difference between them (SMD 0.10, 95 percent CI -0.09 to 0.29), and across 4 RCTs no significant difference for anxiety (SMD 0.04, 95 percent CI -0.22 to 0.29), with FEWER adverse events on saffron. An earlier systematic review and meta analysis of 12 studies (PMID 32221179) found saffron superior to placebo and 'as effective as synthetic antidepressants' for mild to moderate depression, with no difference in adverse event rates. This is a real, replicated, positive result and it should not be reflexively downgraded. What holds it at moderate rather than strong is stated by the authors themselves. The trials are small, short (typically 6 to 8 weeks), single centre, and there is a serious geographic concentration problem: the great majority were conducted in Iran, often by overlapping investigator groups, and reviewers have explicitly called for 'multicenter trials with larger sample size, longer treatment duration, and different ethnic groups' to verify the findings. Publication bias has been detected in this literature. Independent work on Iranian RCTs included in Cochrane reviews found risk of bias mostly high or unclear across randomisation, allocation concealment and blinding. Non inferiority to an SSRI in a small trial is also easier to demonstrate than superiority to placebo in a large one. Beyond depression: the ADHD comparison the seed leans on is a single 6 week pilot RCT in 54 children (Baziar et al., 2019), which showed no significant difference from methylphenidate, but a pilot in 54 children is a hypothesis, not a finding.
30 mg daily of standardised extract, usually split morning and evening. This is the dose used in essentially every positive trial, and it is remarkably consistent across them. Trials ran 6 to 8 weeks. Doses above 5 g are reported to cause toxicity and saffron is a uterine stimulant at high dose.
30 mg standardised extract daily, split morning and evening. 4 to 6 weeks for full effect.
Onset: ~42 days
Generally safe at standard doses. Doses >5g may cause hypothyroidism; >12g potentially toxic.
Pregnancy: avoid
Breastfeeding: caution
Active compounds: crocin, crocetin, safranal, picrocrocin
Remedies using Saffron · Browse by body system · Check it against what you take
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.